Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma
Clinical trial NCT07405255 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07405255
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2027-12-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.